1. Home
  2. GDEV vs RCKT Comparison

GDEV vs RCKT Comparison

Compare GDEV & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDEV
  • RCKT
  • Stock Information
  • Founded
  • GDEV 2009
  • RCKT 1999
  • Country
  • GDEV Cyprus
  • RCKT United States
  • Employees
  • GDEV N/A
  • RCKT N/A
  • Industry
  • GDEV EDP Services
  • RCKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDEV Technology
  • RCKT Health Care
  • Exchange
  • GDEV Nasdaq
  • RCKT Nasdaq
  • Market Cap
  • GDEV 384.5M
  • RCKT 326.4M
  • IPO Year
  • GDEV N/A
  • RCKT N/A
  • Fundamental
  • Price
  • GDEV $16.00
  • RCKT $2.48
  • Analyst Decision
  • GDEV Buy
  • RCKT Buy
  • Analyst Count
  • GDEV 1
  • RCKT 13
  • Target Price
  • GDEV $70.00
  • RCKT $18.50
  • AVG Volume (30 Days)
  • GDEV 19.7K
  • RCKT 4.7M
  • Earning Date
  • GDEV 05-16-2025
  • RCKT 08-04-2025
  • Dividend Yield
  • GDEV N/A
  • RCKT N/A
  • EPS Growth
  • GDEV N/A
  • RCKT N/A
  • EPS
  • GDEV 1.38
  • RCKT N/A
  • Revenue
  • GDEV $420,933,000.00
  • RCKT N/A
  • Revenue This Year
  • GDEV N/A
  • RCKT N/A
  • Revenue Next Year
  • GDEV $17.39
  • RCKT N/A
  • P/E Ratio
  • GDEV $11.32
  • RCKT N/A
  • Revenue Growth
  • GDEV N/A
  • RCKT N/A
  • 52 Week Low
  • GDEV $8.60
  • RCKT $2.19
  • 52 Week High
  • GDEV $42.76
  • RCKT $26.98
  • Technical
  • Relative Strength Index (RSI)
  • GDEV 48.99
  • RCKT 31.96
  • Support Level
  • GDEV $15.79
  • RCKT $2.50
  • Resistance Level
  • GDEV $21.35
  • RCKT $2.70
  • Average True Range (ATR)
  • GDEV 2.20
  • RCKT 0.20
  • MACD
  • GDEV -0.50
  • RCKT 0.11
  • Stochastic Oscillator
  • GDEV 18.60
  • RCKT 4.82

About GDEV GDEV Inc.

GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: